These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
682 related items for PubMed ID: 9658721
21. Altered expression of CD45 isoforms in differentiation of acute myeloid leukemia. Miyachi H, Tanaka Y, Gondo K, Kawada T, Kato S, Sasao T, Hotta T, Oshima S, Ando Y. Am J Hematol; 1999 Nov; 62(3):159-64. PubMed ID: 10539882 [Abstract] [Full Text] [Related]
27. Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation. Vinante F, Rigo A, Tecchio C, Patuzzo C, Ricetti MM, Morosato L, Cassatella MA, Chilosi M, Pizzolo G. Haematologica; 1996 Nov; 81(3):195-200. PubMed ID: 8767523 [Abstract] [Full Text] [Related]
28. CD34/CD117 positivity in assessment of prognosis in children with myelodysplastic syndrome. Tavil B, Cetin M, Tuncer M. Leuk Res; 2006 Feb; 30(2):222-4. PubMed ID: 16098587 [Abstract] [Full Text] [Related]
29. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry. Zelezníková T, Babusíková O. Neoplasma; 2005 Feb; 52(6):517-22. PubMed ID: 16284699 [Abstract] [Full Text] [Related]
33. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F, Chen Y. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783 [Abstract] [Full Text] [Related]
34. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O. Neoplasma; 2007 Aug; 54(6):471-7. PubMed ID: 17949229 [Abstract] [Full Text] [Related]
35. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China. Zheng J, Wang X, Hu Y, Yang J, Liu J, He Y, Gong Q, Yao J, Li X, Du W, Huang S. Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959 [Abstract] [Full Text] [Related]
36. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells. Lanza F, Latorraca A, Moretti S, Castagnari B, Ferrari L, Castoldi G. Cytometry; 1997 Jun 15; 30(3):134-44. PubMed ID: 9222099 [Abstract] [Full Text] [Related]
37. The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance. Lauria F, Raspadori D, Ventura MA, Rondelli D, Testoni N, Tosi P, Michieli M, Damiani D, Motta MR, Tura S. Stem Cells; 1995 Jul 15; 13(4):428-34. PubMed ID: 7549902 [Abstract] [Full Text] [Related]
38. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis. Graf M, Reif S, Kröll T, Hecht K, Nuessler V, Schmetzer H. Am J Hematol; 2006 Apr 15; 81(4):227-35. PubMed ID: 16550517 [Abstract] [Full Text] [Related]
39. Aberrant phenotypes in acute myeloid leukemia: a high frequency and its clinical significance. Bahia DM, Yamamoto M, Chauffaille Mde L, Kimura EY, Bordin JO, Filgueiras MA, Kerbauy J. Haematologica; 2001 Aug 15; 86(8):801-6. PubMed ID: 11522535 [Abstract] [Full Text] [Related]
40. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts. Langebrake C, Creutzig U, Reinhardt D. Klin Padiatr; 2005 Aug 15; 217(3):126-34. PubMed ID: 15858703 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]